0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Alzheimer’s disease (AD) -Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-032
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Alzheimers disease Epidemiology Forecast to 2028

Alzheimer’s disease (AD) -Epidemiology Forecast to 2028

Code: DELV-Epid-032
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Alzheimer’s disease (AD) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Alzheimer’s disease (AD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Alzheimer’s disease (AD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Alzheimer’s disease (AD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Alzheimer’s disease (AD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Alzheimer’s disease (AD) scenario.

Alzheimer’s disease (AD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Alzheimer’s disease (AD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Alzheimer’s disease (AD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Alzheimer’s disease (AD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Alzheimer’s disease (AD)

Key assessments
• Patient Segmentation in Alzheimer’s disease (AD)
• Alzheimer’s disease (AD) Risk & Burden
• Factors driving growth in a specific Alzheimer’s disease (AD) patient population

1. Report Introduction
2. Alzheimer’s disease (AD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Alzheimer’s disease (AD) in 2016
2.2. Patient Share Distribution of Alzheimer’s disease (AD) in 2028
3. Disease Background and Overview: Alzheimer’s disease (AD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Alzheimer’s disease (AD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Alzheimer’s disease (AD) in 7MM – By Countries
5. Epidemiology of Alzheimer’s disease (AD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.1.3. Sub-Type Specific cases of the Alzheimer’s disease (AD) *
5.1.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.1.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.4.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.4.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.4.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.5.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.5.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.5.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.6.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.6.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.6.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.7.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.7.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.7.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.8.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.8.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.8.5. Diagnosed Cases of the Alzheimer’s disease (AD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Alzheimer’s disease (AD)
5.9.3. Sub-Type Specific cases of the Alzheimer’s disease (AD)*
5.9.4. Sex- Specific Cases of the Alzheimer’s disease (AD)*
5.9.5. Diagnosed Cases of the Alzheimer’s disease (AD)
6. Unmet Needs of the Alzheimer’s disease (AD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Alzheimer’s disease (AD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Alzheimer’s disease (AD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Alzheimer’s disease (AD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Alzheimer’s disease (AD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Alzheimer’s disease (AD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Alzheimer’s disease (AD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Alzheimer’s disease (AD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Alzheimer’s disease (AD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Alzheimer’s disease (AD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Alzheimer’s disease (AD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Alzheimer’s disease (AD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Alzheimer’s disease (AD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Alzheimer’s disease (AD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Alzheimer’s disease (AD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Alzheimer’s disease (AD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Alzheimer’s disease (AD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Alzheimer’s disease (AD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Alzheimer’s disease (AD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Alzheimer’s disease (AD) in Japan (2016-2028)


LIst of Figures :

Figure 1: Total Prevalent/Incident Cases of the Alzheimer’s disease (AD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Alzheimer’s disease (AD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Alzheimer’s disease (AD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Alzheimer’s disease (AD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Alzheimer’s disease (AD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Alzheimer’s disease (AD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Alzheimer’s disease (AD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Alzheimer’s disease (AD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Alzheimer’s disease (AD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Alzheimer’s disease (AD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Alzheimer’s disease (AD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Alzheimer’s disease (AD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Alzheimer’s disease (AD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Alzheimer’s disease (AD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Alzheimer’s disease (AD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Alzheimer’s disease (AD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Alzheimer’s disease (AD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Alzheimer’s disease (AD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Alzheimer’s disease (AD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Alzheimer’s disease (AD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Alzheimer’s disease (AD) in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report Forecast 2021 2027
China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6U7133
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Attention Deficit Hyperactivity Disorder ADHD Market Report Forecast 2021 2027
China Attention Deficit Hyperactivity Disorder (ADHD) Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21N5737
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Autism Spectrum Disorder Market Report Forecast 2021 2027
China Autism Spectrum Disorder Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1I362
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Neurodegenerative Disease Market Size Status and Forecast 2021 2027
Global and United States Neurodegenerative Disease Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16X6731
Sat Sep 04 00:00:00 UTC 2021

Add to Cart